Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Samuel Reich Insider Profile
4 Followers
Samuel Reich, Executive VP at Opko Health, holds 980.94K shares in Opko Health (Ticker: OPK), holds 766.70K shares in SAB Biotherapeutics (Ticker: SABS). Most recently, Samuel Reich ― shares of Opko Health on ― for an estimated value of ―.
Profitable Transactions
0 out of 2 Profitable Transactions
Average Return
-73.90%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Samuel Reich holds in companies
Most Profitable Insider Trade
The most profitable trade made by Samuel Reich
Samuel Reich's Trading History
Opko Health
―
Executive VP
―
$1.24M
SAB Biotherapeutics
Nov 30, 2023
CEO & EXECUTIVE CHAIRMAN, Director
Informative Buy
9.79K
$3.26M
List of latest transactions for each holding click on a transaction to see Samuel Reich's performance on stock
You May Also Like
Samuel Reich insider profile FAQ
What is the percentage of profitable transactions made by Samuel Reich?
The percentage of profitable transactions made by Samuel Reich is 0%.
What is the average return per transaction made by Samuel Reich?
The average return per transaction made by Samuel Reich is -73.90%.
What stocks does Samuel Reich hold?
Samuel Reich holds: OPK, SABS stocks.
What was Samuel Reich’s latest transaction?
Samuel Reich latest transaction was an Uninformative Buy of ―.
What was Samuel Reich's most profitable transaction?
Samuel Reich’s most profitable transaction was an Informative Buy of SABS stock on November 30, 2023. The return on the trade was -55.80%.
What is Samuel Reich's role in Opko Health?
Samuel Reich's role in Opko Health is Executive VP.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.